UNS
Click for more information
0.00% 0.5¢ unilife corporation

Amgen's biosimilar candidate to Humira, page-3

  1. ChristopherC
    4,854 Posts.
    lightbulb Created with Sketch. 525
    clock Created with Sketch.
    26/01/16
    11:20
    Post #: 16869489
    With Amgen having success in having biosimilars approved by fta, i suggest this may further future developments with other biosimilars that with an agreement with UNS may see their technology used to deliver these down the track when being approved by fta, and thus lock in a substantial future revenue stream.This is my take on this , has anyone got a different angle?
    UNS Price at posting: 21.5¢ Sentiment: Hold Disclosure: Held
    Likes Created with Sketch. 2  Upvote
    lightbulb Created with Sketch.  Great analysis
    Stroke 3 Created with Sketch. Comments Created with Sketch. Reply

  2. Top Stories

 

Featured News

NEU Neuren Pharmaceuticals dips after pediatric Angelman Syndrome Phase 2 trial results fail to impress
right-arrow Created with Sketch.
TG6 TG Metals reports high grade lithium hits approaching 3% at Jaegermeister
right-arrow Created with Sketch.
RLT South Africa-based Renergen brings liquid helium facility online
right-arrow Created with Sketch.
QBE QBE records share price plunge despite doubling profits in the first half of 2024
right-arrow Created with Sketch.
NEWS Dale Gillham's weekly wrap: picking resilient stocks in a volatile global market
right-arrow Created with Sketch.
NEWS Bitcoin: Current State of Play & Where to Next | Swyftx
right-arrow Created with Sketch.
watchlist Created with Sketch. Add UNS (ASX) to my watchlist

Currently unlisted public company.

arrow-down-2 Created with Sketch. arrow-down-2 Created with Sketch.